Dr. Peter Haug
About
Academic background, professional career, scientific publications and speaking activities — from analytical chemistry research through pharmaceutical M&A to serial founding angel activity.
Academic background, professional career, scientific publications and speaking activities — from analytical chemistry research through pharmaceutical M&A to serial founding angel activity.
Universität Stuttgart · Stuttgart, Germany
Thesis: Prof. Eisenbach · VCI Dissertation Scholarship
FernUniversität Hagen
Schwerpunkt Technology Management & Innovation
Universität Stuttgart & École Supérieure de Chimie Industrielle Lyon
Artur-Fischer-Preis · ERASMUS Grant 1995
Dr. Peter Haug spent over 20 years in senior management at some of Europe's leading chemical and pharmaceutical companies — building the experience that now powers his work as a Founding Angel.
As Member of Management Board at Corden Pharma (ICIG), a European CDMO with ~1,500 employees and €250M in revenue, he led strategic planning, marketing & sales, R&D coordination and integration of acquired pharmaceutical businesses.
As Investment Manager at International Chemical Investors Group (ICIG), a private industrial holding with ~3,000 employees and €700M revenue, he was acquisition lead for major transactions — including assets from AstraZeneca, Bristol-Myers Squibb, Genzyme, Roche and Solvay. ICIG's pharmaceutical platform, Corden Pharma, was subsequently sold to Astorg Partners in 2022 for approximately $2.6 billion.
This corporate background — combined with a doctorate in Chemistry — created the foundation for his second career as a Founding Angel: deep know-how, trusted networks, and the credibility to open doors for early-stage ventures.
Member, Gesellschaft Deutscher Chemiker (GDCh) · Rechnungsprüfer GDCh · SeedUp Investor Network · BioRN Life Sciences Cluster
From analytical chemistry research through pharmaceutical consulting to serial founding angel activity — a career built on the intersection of deep scientific expertise and entrepreneurial practice.
Before founding his own ventures, Dr. Haug spent a decade in top-tier management consulting and senior industry roles — building the network, deal experience and operational depth that now serve his portfolio companies.
Peer-reviewed articles and invited contributions to leading analytical chemistry, life sciences and industry trade publications — spanning Raman spectroscopy, cell culture technology, bio-fuels and molecular diagnostics.
Additional trade press coverage, conference proceedings and invited contributions available on request. Please contact Dr. Peter Haug directly.
Over 100 speaking engagements, panel discussions, investor presentations and jury activities at leading conferences, trade fairs and start-up events across Germany, Europe and internationally.
World's leading medical technology fair. Partnering presentations for noscendo and oncgnostics portfolio companies.
Europe's leading life sciences partnering events. Investor and partner meetings for diagnostics portfolio companies.
World's leading healthcare investment conference. Investor meetings and strategic intelligence.
Invited speaker on rapid pathogen diagnostics, epigenetic cancer tests and companion diagnostics.
Speaker on molecular diagnostics for infectious diseases and applications of next-generation sequencing in clinical settings.
Jury member at one of Baden-Württemberg's leading technology start-up awards. 300Microns won the award in 2014.
Active investor and mentor in the SeedUp network for early-stage life sciences start-ups in the Rhein-Neckar technology region.
Regular participation in Rhein-Neckar life sciences cluster events as speaker, panelist and investor representative.
Invited speaker at university technology transfer events on the practical aspects of academic spin-out formation, funding and business development.
Panelist on sustainable aviation fuel (SAF) and biofuel technology commercialization during Greasoline's development phase (2011–2014).
Full list of 100+ talks and events (2012–2024) available on request.
Request full events list →